SARTORIUS AG |
Market Closed -
Other stock markets
|
Pre-market 11:35:51 am | |||
| 231.5 EUR | +2.66% |
|
232 | +0.22% |
| 13/05 | Sartorius Partners With Sanofi for Biomanufacturing Platform | MT |
| 30/04 | SARTORIUS : Target cut by -6.1% |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 3.57B 3.89B 325B | Sales 2025 * | 4.02B 4.37B 365B | Capitalization | 18.12B 19.71B 1,646B |
|---|---|---|---|---|---|
| Net income 2024 * | 213M 232M 19.35B | Net income 2025 * | 342M 372M 31.07B | EV / Sales 2024 * | 6.21 x |
| Net Debt 2024 * | 4.05B 4.41B 368B | Net Debt 2025 * | 3.82B 4.15B 347B | EV / Sales 2025 * | 5.46 x |
| P/E ratio 2024 * |
77.5
x | P/E ratio 2025 * |
54
x | Employees | 14,614 |
| Yield 2024 * |
0.29% | Yield 2025 * |
0.39% | Free-Float | 35.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sartorius AG
More press releases
More news
| 1 day | +2.66% | ||
| 1 week | +4.51% | ||
| Current month | +5.23% | ||
| 1 month | -11.64% | ||
| 3 months | -12.97% | ||
| 6 months | +6.44% | ||
| Current year | -12.64% |
1 week
218.00
235.00
1 month
204.00257.50
Current year
204.00290.00
1 year
181.00310.50
3 years
181.00834.00
5 years
138.50834.00
10 years
22.50834.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/99/01 | |
| Chief Tech/Sci/R&D Officer | 59 | 01/95/01 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 01/01/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 01/20/01 |
| Director/Board Member | 58 | 06/17/06 | |
Lothar Kappich
CHM | Chairman | 67 | 01/07/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 391 M€ | +9.18% | - | |
| 0.00% | 34 M€ | +8.23% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/24/15 | 231.5 | +2.66% | 2,429 |
| 14/24/14 | 225.5 | +2.50% | 3,532 |
| 13/24/13 | 220 | -0.68% | 1,634 |
| 10/24/10 | 221.5 | -1.12% | 2,626 |
| 09/24/09 | 224 | +1.13% | 1,783 |
Delayed Quote Xetra, May 15, 2024 at 09:05 pm IST
More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
01:30pm
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
292.9
EUR
Average target price
329.2
EUR
Spread / Average Target
+12.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -39.00% | 3.01B | |
| +22.02% | 1.94B | |
| -0.62% | 1.66B | |
| +33.51% | 1.34B | |
| -16.17% | 965M | |
| -22.01% | 895M | |
| +5.38% | 827M | |
| -23.80% | 638M | |
| +8.96% | 516M |
- Stock Market
- Equities
- SRT3 Stock
- SRT Stock